-

10:39:55 AM

BAX Stock News

BAX - Baxter International Inc.

10/21/21 5:00 PM

NYSE, OTC : BAX, BMXXY

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Baxter International Inc., a global leader in acute care, and bioMérieux, a global leader in in vitro diagnostics, today announced the CE marking of the NEPHROCLEAR™ CCL14 Test. The companies intend to commercially launch the NEPHROCLEAR™ CCL14 Test in western Europe in 2022.. “Baxter is proud to partner with bioMérieux to...

RHEA-AI

neutral

10/13/21 4:15 PM

NYSE : BAX

conferences

Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference

Baxter International Inc., a leading global medical products company, will present at the Credit Suisse 30 th Annual Virtual Healthcare Conference on Monday, November 8, 2021. Jay Saccaro, Baxter’ s chief financial officer, is scheduled to present at 8:50 a.m. Eastern Time. Media Contact Steve Brett, 948-5353 media@baxter.com.

RHEA-AI

neutral

10/05/21 8:00 AM

NYSE : BAX

Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress

Baxter International Inc., a global leader in acute care, announced the presentation of data from three critical care studies at the 34 th Annual European Society of Intensive Care Medicine LIVES virtual congress taking place Oct. 3– Oct. 6, 2021. “Baxter is dedicated to advancing research that helps clinicians optimize care and improve outcomes for the most...

RHEA-AI

neutral

09/27/21 4:05 PM

NYSE : BAX

conferencesearnings

Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors

Baxter International Inc., a leading global medical products company, will host a conference call to discuss its third-quarter 2021 financial results on Thursday, October 28, 2021 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/3534264 to pre-register for...

RHEA-AI

neutral

09/23/21 9:00 AM

NYSE : BAX

fda approval

Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation

Baxter International Inc., a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection. “In a critical care situation, speed, efficiency and safety are of the utmost priority,” said Heather Knight, general...

RHEA-AI

neutral

09/02/21 3:43 PM

NYSE : BAX, HRC

acquisition

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Hill-Rom Holdings, Inc.

Rowley Law PLLC is investigating potential securities law violations by Hill-Rom Holdings, Inc. (NYSE: HRC) and its board of directors concerning the proposed acquisition of the company by Baxter International Inc. (NYSE: BAX). Stockholders will receive

RHEA-AI

neutral

09/02/21 7:00 AM

NYSE : BAX, HRC

acquisition

Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally

Baxter International Inc., a leading global medical products company, and Hillrom, a global medical technology leader, today announced that the companies have entered into a definitive agreement under which Baxter has agreed to acquire...

RHEA-AI

positive

08/18/21 8:30 AM

NYSE : BAX

partnership

The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia

The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF USA today announced a partnership to improve access to safe water in La Guajira, Colombia, one of the country’s most water-challenged regions. A $1.5 million grant from the Foundation is

RHEA-AI

neutral

08/02/21 4:15 PM

NYSE : BAX

Baxter Advances Enterprise Digital Transformation in Collaboration With AWS

Baxter International Inc. (NYSE:BAX), a global medical products company, is accelerating its companywide digital transformation across three strategic areas – developing new digital health solutions to personalize and improve patient care; creating seamless experiences for healthcare customers and

RHEA-AI

positive

07/29/21 4:15 PM

NYSE : BAX

conferences

Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 in Laguna Beach, Calif. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Pacific

RHEA-AI

neutral

1 2 3 4 5 6 Next

BAX Data:

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.baxter.com
CeoJose Almeida
Security nameBaxter International Inc.
Issue typecs
SectorManufacturing
Sic code3841
Employees2020
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address1 Baxter Pkwy
StateIllinois
CityDeerfield
Zip60015-4625
CountryUS
Phone18479482000

BAX Description:

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.